Streamex Corporation (STEX): Market Capitalization-to-Revenue Ratio

Corporate company logo of biosig.com (STEX)

The resilience of Streamex Corp (STEX) depends on the commercial success of its biophysical developments and the recognition of its heart monitoring systems. The price-to-sales ratio visualizes these risks, with the value fixed at 235.80. The holding company is modernizing its biomedical assets through IT innovations and cloud databases. Streamex Corp is currently undergoing a large-scale restructuring, focusing on the search for new IT technologies and venture capital investments.

STEX Streamex Corp: P/S Multiple in the range 09/13/2025 - 11/13/2026

Streamex Corp (STEX) - metric breakdowns and financial figures

- stock value and consensus price forecast:
- stock exchange capitalization data:
Fundamental company analysis:Streamex Corporation, STEX
Core merchandise of Streamex Corp.

The P/S multiple reflects the market value of one dollar of revenue, allowing for an assessment of investor confidence in the company's ability to generate income. By analyzing the price-to-sales multiple, one can determine the extent to which the current capitalization of Streamex Corp (STEX) is justified amid a radical shift in the business model and the search for new IT technologies to attract venture financing.